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Objective: To investigate the inﬂuence of autophagy on sensitivity to the chemotherapy
drug cisplatin (DDP) and the role of PI3K in autophagy.
Methods: MTT methods and ﬂow cytometer, with rapamycin up-regulating the auto-
phagy and 3-MA down-regulating the autophagy, were employed to measure the pro-
liferation inhibition rate on DDP-treated osteosarcoma cells and the change in cell cycle.
The expression of intracellular protein was detected by Western blot. The autophagy of
MG63 cell was observed using ﬂuorescence microscope and transmission electron
microscope.
Results: Western blot showed that basic autophagy level of MG63 cell was signiﬁcantly
lower than that of hFOB cell. MTT test revealed that the cell proliferation inhibition rate
in the group treated with rapamycin and DDP, group treated with 3-MA and DDP, and
group only treated with DDP was signiﬁcantly different. It was demonstrated by the ﬂow
cytometry that in group treated with DDP, inhibition on autophagy can increase the cell
numbers in G1 phase and reduce the cell numbers in S phase of cell cycle. Increase of
autophagosome in MG63 cytoplasm was observed under ﬂuorescence microscope.
Conclusions: Up-regulating the autophagy signiﬁcantly reduced the sensitivity of MG63
cell to chemotherapy with DDP. DDP induced autophagy of MG63 cell and blocked the
cell cycle at G1 phase.1. Introduction
Osteosarcoma is one of the most common malignant bone
tumor in adolescent [1]. With high malignant degree and poorer
prognosis, osteosarcoma seriously inﬂuences the prognostic
survival of patients. Although the present classical surgery
combined with neoadjuvant chemotherapy can signiﬁcantly
improve patient's life quality and raise the survival rate, the
relapse, metastasis and multi-drug resistance to chemotherapy
heavily threaten the long-term survival rate of patients [2–4].
Therefore, it is very important to enhance the sensitivity ofosteosarcoma to chemotherapy and study its molecular
mechanism during the process of clinical treatment.
Autophagy is the main means, which is relatively conservative,
to degrade autologous organelles or protein in evolutionary of
eukaryocyte [5], regulating and controlling the cell proliferation
and function. A study showed that the level of autophagy
activity plays an important role in occurrence and development
of malignant tumor [6]. Microtubule-associated protein 1 light
chain 3 (LC3) is located at the membrane surface of pre-
autophagosome and autophagosome, and it is usually used as
speciﬁc marker of autophagy level [7]. As the main gene for
regulation of autophagy, Beclin-1 is also regarded as maker of
autophagy; it can inhibit the tumor growth through enhancement
of autophagy, being an important autophagy-associated tumor
suppressor gene [8]. Molecular signaling pathway of
phosphatidylinositol 3-kinase (PI3K) is involved in regulation of
cell proliferation, apoptosis, relapse andmetastasis etc. In addition,
PI3K/Akt plays an important role in tumor cell proliferation,
apoptosis, autophagy, relapse andmetastasis aswell as degradationopen access article under the CC BY-NC-ND
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of PI3K/Akt can facilitate programmed cell death, thus inhibiting
the tumor growth. Hence, drugs targeting the inhibition of PI3K/
Akt are more and more valued in tumor research.
There is still controversy regarding the role of autophagy in
tumor treatment [10], and the inhibition and protective effects of
autophagy during tumor treatment need to be further elaborated.
In the present study, human osteosarcoma cell MG63 was
treated with autophagy inhibitor 3-methyladenine (3-MA),
autophagy promoter rapamycin, PI3K inhibitor LY294002 and
clinical commonly used chemotherapy drug cisplatin (DDP), to
detect cell proliferation activity, cell cycle and changes in mo-
lecular level of autophagy, so as to investigate the changes of
autophagy activity and molecular mechanism of PI3K/Akt dur-
ing autophagy in the chemotherapy of osteosarcoma, providing
theoretical basis for combined chemotherapy in treatment of
osteosarcoma.
2. Materials and methods
2.1. Cell line
Human osteoblast hFOB and osteosarcoma cell MG63 were
purchased from Cell Bank of Chinese Academy of Science and
cultured in DMEM medium containing 10% fetal bovine serum
(Gibco), 100 IU/mL penicillin, 100 mg/mL streptomycin at
37 C and 5% CO2 condition. Cisplatin, DDP, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
3-MA, rapamycin and LY294002 were purchased from Sigma
company.
Respective treatments: No drug was give to the control
group; Group DDP was treated with 10 mg/mL DDP; Group
PI3K inhibitor was treated with 5 mmol/L PI3K speciﬁc inhibitor
LY294002; Group RAPA was treated with 10 mmol/L rapa-
mycin; Group 3-MA was treated with 5 mmol/L 3-MA; Group
DDP + PI3K inhibitor was treated with 5 mmol/L LY294002 and
10 mg/mL DDP; Group DDP + RAPA was treated with 10 mmol/
L rapamycin, and 1 h later, 10 mg/mL DDP was added; Group
DDP+3-MA was treated with 5 mmol/L 3-MA, and 1 h later,
10 mg/mL DDP was added.
2.2. Detection of cell proliferation activity by MTT
method
1 × 104 cells at logarithmic phase were inoculated in 96-well
plate with each well. Different drugs were added and the plate
was cultured for 24 h. Then 20 mL MTT solution (5 mg/mL) was
added into each well and cultured for 4 h. Culture solution was
removed, and each well was added with 150 mL dimethylsulf-
oxide and shaken for 10 min. ELISA plate reader was used to
measure the absorbance (OD) at 490 nm. Cell proliferation in-
hibition rate (%) = (1−ODtest group/ODcontrol group) × 100%.Table 1
Primer sequences used for real-time ﬂuorescent quantitative PCR.
Primer Sense (50–30)
GAPDH CATCTTCTTTTGCGTCGCCA
PI3K CATCACTTCCTCCTGCTCTAT
Bcl-2 CGACGACTTCTCCCGCCGCTACCG
Beclin-1 AAGAGAGAGCGATGGTAG2.3. Analysis of cell cycle by ﬂow cytometry
Human osteosarcoma cells MG63 from different groups were
inoculated in 6-well plate. After cell adherence, the cells were
treated with different drugs for 36 h, and collected, centrifuged,
washed with phosphate buffer solution (PBS) and added with
4 C 70% ethanol for overnight. Then the cells were centrifuged,
added with 150 mL propidium iodide and 150 mL RNaseA so-
lution for staining for 30 min at 4 C avoiding the light. BD
FACSort CellQuest software of ﬂow cytometry was used to
analyze the cell cycle and obtain percentage of cell cycle.
2.4. Observation of cell morphological change through
transmission electron microscope
Cells at logarithmic phase were interfered with different
drugs for 72 h, ﬁxed by 3% glutaraldehyde for 2 h, washed by
PBS for 10 min for 3 times, then ﬁxed by 2% osmic acid for 2 h
and washed by PBS for 10 min for 3 times. The cells were
dehydrated using gradient ethanol which is then replaced with
acetone, embedded and aggregated. The parafﬁn-embedded cells
were trimmed, cut into ultrathin sections, stained with uranium
and subsequently with lead. Then the cell morphology and
structure were observed under transmission electron microscope.
2.5. Real-time quantitative PCR
Cells from different groups were collected and total RNA
was extracted according to instruction of TRIzol. About 2 mg of
RNA was used to construct 25 mL reverse transcription system,
and the reverse transcription was performed at 42 C for 60 min
and then 75 C for 10 min. Then 1 mL reverse transcription
product was used as template to amplify using SYBR® Premix
Ex Taq™II. PCR reaction was performed at 94 C for 2 min,
94 C for 30 s and 60 C for 34 s with a total of 35 cycles. The
value of 2−DD Ct was used to indicate the relative expression
level of target gene mRNA. The primer sequences are shown in
Table 1.
2.6. Western blot analysis
Cells were lysed on ice for 20 min using RIPA lysis buffer,
and centrifuged at 12000 rpm at 4 C for 20 min. The super-
natant was collected and concentration of protein sample was
quantitatively measured by BCA. About 80 mg total protein was
separated by SDS-PAGE, transferred to PVDF membrane and
blocked by 5% skimmed milk at room temperature for 2 h.
Proper proportion of primary antibody (Cell Signaling Tech-
nology) was added, and the mixture was placed overnight at
4 C. Then membrane was washed for 3 times (6 min each
wash). HRP-labeled goat anti-rabbit and goat anti-mouse sec-
ondary antibodies were added respectively (1:5000). TheAntisense (50–30)
TTAAAAGCAGCCCTGGTGACC
CAGTTGTTGGCAATCTTCTTC
C CCGCATGCTGGGGCCGTACAGTTCC
CTGGGCTGTGGTAAGTAA
Figure 2. Effect of autophagy on sensitivity to chemotherapy with DDP.
Compared with DDP, *indicate P < 0.05, **indicate P < 0.01, ***indicate
P < 0.001.
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in darkroom by ECL developer. The relative expression was
indicated by the gray value ratio of target protein and internal
reference protein.
2.7. Intracellular expression of GFP-LC3 fusion protein
MG63 cell was transfected with GFP-LC3 plasmid according
to the instruction of Lipofectamine2000. Stable GFP-LC3 fusion
protein was treated under different conditions for 24 h. The
culture solution was then removed, and cells were washed by
PBS for 2 times, observed and photographed by laser scanning
confocal microscope.
2.8. Statistical analysis
Statistical analysis was conducted using SPSS13.0 software.
Data was expressed as mean ± SD. t-Test and One-way ANOVA
were used to compare data between two groups and data among
multiple groups respectively. Difference was statistically sig-
niﬁcant when P < 0.05.
3. Results
3.1. Expression of autophagy associated protein in
human osteosarcoma cells
The expression of autophagy associated protein PI3K, Bcl-2
and Beclin-1 as well as LC3-I/LC3-II protein in MG63 and
hFOB was detected by Western blot. LC3, the homologue of
yeast Atg, is a marker on membrane of autophagosome. When
autophagy is enhanced, expression levels of LC3-I and LC3-II
are lowered and increased respectively. Beclin-1, the homologue
of yeast, can accelerate the formation of autophagosome; and itsFigure 1. Expression of autophagy associated protein in osteoblast and human
**MG63 compared with hFOB, P < 0.01.expression level can reveal the degree of autophagy. Relative
amount of autophagic marker protein LC3-II/LC3-I and Beclin-1
in human osteosarcoma cells was signiﬁcantly lower than that in
normal osteoblast (Figure 1) (P < 0.01), indicating that the basic
autophagic activity of MG63 cell is lower than that of hFOB
cell. The expression of anti-apoptotic protein Bcl-2 and PI3K
was signiﬁcantly increased (P < 0.01). Therefore, lowering of
autophagic level, inhibition on apoptosis and abnormal expres-
sion of PI3K play an important role in occurrence and devel-
opment of osteosarcoma.osteosarcoma MG63 cell.
Figure 3. Inhibition on MG63 cells by different treatment.
Compared with DDP, **indicate P < 0.01, ***indicate P < 0.001.
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to chemotherapy with DDP
Osteosarcoma cell was treated with DDP (10 mg/mL),
different concentrations of autophagy inhibitor 3-MA (1, 5 and
50 mmol/L) and autophagy promoter rapamycin (1, 10 and
100 mmol/L) to verify the effect of autophagy on osteosarcoma
cell sensitivity to chemotherapy with DDP. The results of MTTFigure 4. Changes in expression of PI3K, Bcl-2 and Beclin-1 in MG63 cells
Compared with DDP, *indicate P < 0.05, **indicate P < 0.01, ***indicate P <test are showed in Figure 2. Rapamycin at 1 mmol/L and
10 mmol/L can weaken the sensitivity of MG63 cell to DDP,
lowering the inhibition rate. This effect was signiﬁcantly
different from that in cells only treated with DDP; when the
concentration of rapamycin was increased to 100 mmol/L, it
showed a reverse result. Hence, rapamycin at 10 mmol/L was
selected to perform the subsequent experiment. 3-MA at 1–
50 mmol/L dose-dependently increased the inhibition rate of
DDP on MG63 cells. Signiﬁcant difference was observed at
5 mmol/L and the inhibition rate achieved about 82%. However,
the inhibition rate was too high at 50 mmol/L, and cells can
hardly survive. Therefore 3-MA at 5 mmol/L was used to
conduct the subsequent experiment. This experiment revealed
that interdicting autophagy can promote the inhibitory effect of
DDP on MG63 cell activity.
3.3. Role of PI3K in MG63 cell autophagy and
sensitivity to chemotherapy
MG63 cells at logarithmic phase were treated with different
drugs. Cells in each group were incubated for 24 h and used for
the subsequent experiment. MTT test revealed that after inter-
dicting autophagy, 3-MA facilitated the inhibition of DDP on
MG63 cell growth. After promoting autophagy, rapamycin
reduced inhibition of DDP on MG63 cell growth. After inhib-
iting PI3K, LY294002 reduced inhibition of DDP on MG63 cell
growth. These results were signiﬁcantly different (Figure 3)from different groups.
0.001.
Table 2
Proportion of GFP-LC3 positive cells detected by ﬂow cytometry.
Groups GFP-LC3+ cell proportion (%)
CON 29.57 ± 2.89
DDP 52.27 ± 1.76
PI3K inhibitor 44.20 ± 5.54
Rapamycin 89.60 ± 2.55
3-MA 12.90 ± 1.75
DDP + PI3K inhibitor 75.37 ± 4.92
DDP + Rapamycin 94.53 ± 1.10
DDP + 3-MA 85.60 ± 2.97
Table 3
Cell cycle of MG63 cells from different groups.
Groups G1 G2 S
Con 56.74% 20.27% 22.99%
DDP 74.02% 8.25% 17.73%
PI3K inhibitor 76.02% 10.27% 13.53%
RAPA 83.95% 6.33% 9.72%
3-MA 56.76% 10.19% 33.05%
DDP + PI3K inhibitor 87.08% 6.70% 6.22%
DDP + RAPA 91.18% 4.96% 3.86%
DDP + 3-MA 80.13% 7.91% 11.96%
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important role in sensitivity of MG63 to chemotherapy with
DDP, and inhibition on autophagy can enhance the sensitivity to
chemotherapy; however, promotion of autophagy weakened the
sensitivity to chemotherapy. PI3K exhibited an important inhi-
bition effect on autophagy.Figure 5. Changes in cell cycle of different groups showed by ﬂow cytometry3.4. Inﬂuence of DDP on autophagy associated protein
in MG63 cell
The expression of mRNA (Figure 4B, C, D) and protein
(Figure 4A) of autophagy associated protein PI3K, Bcl-2 and
Beclin-1 in MG63 cells from different groups was measured. It
was found that DDP can signiﬁcantly inhibit the expression of
PI3K and Bcl-2 and promote the expression of Beclin-1. When
3-MA was used to inhibit autophagy, expression of PI3K and
Beclin-1 was partially raised again, but when rapamycin was
used to accelerate autophagy, expression of PI3K was partially
lowered; PI3K inhibitor LY294002 can signiﬁcantly enhance the
inhibition of DDP on PI3K and Bcl-2, and its promotion on
Beclin-1. It is well-proved that DDP inhibited the expression of
PI3K and Bcl-2 and promoted the expression of Beclin-1,
indicating that DDP exhibited anti-cancer effect partially
through enhancement of cell autophagy. PI3K plays an impor-
tant role in the cell autophagy process; PI3K inhibitor can
signiﬁcantly increase the sensitivity to chemotherapy with DDP,
thus enhancing the lethal effect on osteosarcoma cells and
providing new insight into new combined chemotherapy for
clinical treatment.
3.5. Effect of DDP on degree of MG63 cell autophagy
Flow cytometry was used to detect the autophagy of GFP-
LC3 fusion protein in MG63 cell. As showed in Table 2,
PI3K inhibitor can facilitate the autophagy of MG63 cell, dis-
playing the inhibition effect of PI3K on cell autophagy. Rapa-
mycin can promote autophagy, thus enhance the inhibition effect
of DDP..
Figure 6. DDP-induced MG63 cell autophagy activation detected by LC3-II ﬂuorescence.
Figure 7. Ultramicro structure of MG63 cell observed under transmission electron microscope.
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The impact on GFP-LC3 fusion cell cycle was studied by
ﬂow cytometry. As showed in Table 3 and Figure 5, DDP can
increase the cell number of MG63 cell at G1 phase, and reduced
the cell number at S phase. The results revealed that DDP can
block MG63 cells at G1 phase of the cell cycle, and PI3K in-
hibitor can increase the inhibition effect of DDP.
3.7. Changes of DDP-induced cell autophagy detected
by GFP-LC3 ﬂuorescence
As showed in Figure 6, autophagy speciﬁc marker protein
LC3, which is marked by green ﬂuorescent protein, revealed
dot-like scattered distribution of autophagy around on the cell
membrane. When rapamycin promoted the autophagy, ﬂuores-
cence agglutination was increase, forming graininess-like ﬂuo-
rescence agglutination spot.3.8. Inﬂuence of DDP on cell morphology and structure
observed by transmission electron microscope
Changes of ultramicro morphology and structure of MG63
cells was observed under transmission electron microscope. As
showed in Figure 7, organelles and chromosome morphology in
cytoplasm of control group were normal. After interference of
different treatment, Group DDP which promoted the autophagy
showed a lot of double membrane structure in cytoplasm and
many autophagosome.
4. Discussion
Mechanism of occurrence and development of malignant
tumor is complicated, and it has not been clariﬁed yet. With the
development of surgery combined neoadjuvant chemotherapy,
the prognosis of osteosarcoma is remarkably improved [11].
Resistance to chemotherapy drugs heavily inﬂuenced the
Xu-Dong Miao et al./Asian Paciﬁc Journal of Tropical Medicine 2015; 8(9): 731–738 737effectiveness of the chemotherapy drugs. Therefore, discovery
of effective drugs that can increase the sensitivity to
chemotherapy plays an important role in anti-tumor effect.
Chemotherapy drugs kill the tumor cells through autophagy,
necrosis, apoptosis and mitotic mutation etc [12]. Chemotherapy
drug induces the occurrence of tumor cell autophagy, namely, it
together with apoptosis can induce cell necrosis, and it also acts
as survival mechanism for the self-protection of tumor cells in
adverse environment [13]. Adjuvant chemotherapy is signiﬁcant
in treatment of osteosarcoma, and patient's sensitivity to
chemotherapy drugs is the key factor that affects the
prognostic [14].
In the present research, the expression of LC3 and Beclin-1,
the important regulatory factors for autophagy was studied
ﬁrstly. LC3 appears as LC3-I and LC3-II in the cytoplasm, but
LC3-I is converted to LC3-II when autophagy occurs. LC3-II is
the signiﬁcant protein of autophagosome which is considered as
the molecular marker of autophagosome, so the ratio of LC3-II/
LC3-I was employed to reﬂect the degree of cell autophagy [15].
Our ﬁndings showed that the ratio of LC3-II/LC3-I in MG63
cell was remarkably lower than that in osteoblast, revealing
the lower autophagy activity of MG63 cells compared with
normal cells. In addition, we found that the expression of
PI3K in osteosarcoma cells are signiﬁcantly increased, which
may be related to the lowering of autophagy activity. Hence
in the experiment, MG63 cells were treated with DDP, and
the result revealed that DDP can up-regulate the ratio of LC3-
II/LC3-I, down-regulate the expression of Beclin-1, and
remarkably decrease the MG63 cell proliferation activity, indi-
cating that DDP can promote the autophagy of MG63 cell.
Beclin-1 is a speciﬁc gene regulating the autophagy, and it is
involved in regulation of autophagy by interaction with multiple
protein [16]. The results of our experiment displayed gradual
increase of DDP-induced Beclin-1 expression, which illus-
trated that DDP can induce MG63 cell autophagy. Meanwhile,
it can be presumed that DDP facilitates MG63 cell autophagy
and inhibites MG63 cell proliferation activity by inhibiting the
expression of PI3K according to the decrease in expression of
PI3K, moreover, autophagy was promoted with the increase in
concentration of rapamycin, but the proliferation inhibition rate
of DDP was obviously lowered. However, autophagy was
inhibited with increase in concentration of 3-MA, and the
proliferation inhibition rate of DDP was signiﬁcantly raised.
This result indicates that up-regulation of autophagy can
remarkably reduce the sensitivity of DDP-treated osteosarcoma
cells to chemotherapy. The inhibition effect of autophagy on
sensitivity to chemotherapy with DDP fully proves the impor-
tant role of autophagy in occurrence and development of oste-
osarcoma. Inhibition on autophagy can signiﬁcantly enhance the
sensitivity of osteosarcoma cells to chemotherapy drugs [17].
Pathway of PI3K/Akt is vital in cell proliferation,
differentiation and apoptosis etc, and it is also an important
signaling pathway regulating the cell autophagy [18]. A
research stated that under environmental stress, PI3K/Akt can
mediate rapamycin protein mTOR, negatively regulating the
cell autophagy [19]. When autophagy is inhibited by
LY294002, proliferation inhibition rate of DDP was
signiﬁcantly increased. The effect of autophagy on DDP
inhibiting MG63 cell activity was observed in this study for
the ﬁrst time. Our ﬁndings showed that the cell proliferation
inhibition rate in Group DDP + rapamycin was lower than itscounterpart in Group DDP, indicating that up-regulation of
autophagy can remarkably reduce the sensitivity of osteosar-
coma cells to chemotherapy drug DDP, which provide theo-
retical basis for further anti-cancer treatment.
In conclusion, autophagy participates in the anti-tumor effect
of chemotherapy drugs, lowering the sensitivity to chemo-
therapy. A study found that activation of autophagy can induce
cell death, but autophagy can protect the effect of anti-tumor
therapy by inhibiting tumor cell apoptosis [20]. The cell cycle
analyzed by ﬂow cytometry in the present study showed that
when MG63 cell was treated with DDP, the cell number of
MG63 cell increased at G1 phase, and reduced at S phase.
PI3K can enhance the inhibition effect of DDP, which
displayed that DDP can block the growth cycle of MG63
cells, thus inhibiting the cell growth. PI3K inhibitor can
increase the sensitivity to chemotherapy with DDP. The main
characteristics of autophagy in cell morphology is the presence
of vesicle with double membrane [21]. Observation under
transmission electron microscope revealed that after MG63
cell was treated with DDP, there was remarkable increase in
formation of autophagosome with double membrane structure
around the cytoplasm and organelles. This indicated that DDP
can facilitate the activation of MG63 cell autophagy. Through
ﬂuorescent protein detection test for LC3, it was found that
dot-like green ﬂuorescence was distributed around on the cell
membrane, which revealed the activation of autophagy. This
fully illustrated that autophagy is involved in osteosarcoma cell
proliferation inhibited by DDP as well as the cell cycle. Based
on the previous research ﬁndings, the present study investigates
the inﬂuence of DDP on human osteosarcoma cell proliferation
and the cell autophagy, but the mechanism of speciﬁc molecular
signaling pathway need to be further studied. This present study
provides research basis for relation of cell cycle, cell prolifera-
tion and autophagy, offering theoretical basis for further clinical
treatment of osteosarcoma.
Autophagy can scavenge the abnormal organelle, cell nu-
cleus and protein, protecting the cell. During the process of anti-
tumor treatment, autophagy can protect the cell, scavenge
intracellular toxic substance, reduce toxicity of chemotherapy
drugs and lower sensitivity to chemotherapy under environ-
mental stress [22]. Meanwhile, the activation of autophagy is
enhanced, accelerating the cell death. Therefore, induction and
enhancement of tumor cell autophagy activity become the new
insight into anti-tumor research [23]. Intensive study on
regulatory mechanism of autophagy and effect mechanism of
autophagic cell death in development of tumor, how to induce
improvement of cell autophagy activity, as well as autophagy
in sensitivity to anti-tumor chemotherapy drugs is of very
important clinical value for anti-tumor treatment. The present
study found that chemotherapy drug DDP can effectively induce
autophagic activation of MG63 cell and inhibit the cell prolif-
eration activity, and the signiﬁcant role of autophagy in drug-
resistant tumor cell is also observed. Consequently, subtle
regulation of autophagy will be promising in treatment of tumor,
and this will provide the important theoretical basis for tumor
treatment by combining chemotherapy drugs with autophagy
regulator.
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